Glucose variability is associated with intensive care unit mortality

Critical Care Medicine

Volumn 38, Issue 3, 2010, Pages 838-842

  Hermanides, Jeroen ^a   Vriesendorp, Titia M ^a   Bosman, Robert J ^b   Zandstra, Durk F ^b   Hoekstra, Joost B ^a   Devries, J Hans ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Epidemiology; Glucose; Intensive care unit; Metabolism; Mortality; Physiological stress

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ALGORITHM; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; PRIORITY JOURNAL; TEACHING;

EID: 77249148309     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181cc4be9     Document Type: Article

References (38)

1. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
2. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
3. Van den Berghe GMP, Wouters PJM, Bouillon RM, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
4. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
5. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300: 933-944
6. Arabi YMM, Dabbagh OCM, Tamim HMM, et al: Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008; 36:3190-3197
7. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
8. Preiser JC, Devos P, Ruiz-Santana S, et al: A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The GluControl study. Intensive Care Med 2009; 35:1738-1748
9. Bagshaw SM, Bellomo R, Jacka MJ, et al: The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009; 13:R91
10. Egi M, Bellomo R, Stachowski E, et al: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-252
11. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54:1615-1625
12. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al: Loss of endothelial glycocalyx during acute hyperglycemia coincides with en-dothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55:480-486
13. Stegenga ME, van der Crabben SN, Levi M, et al: Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinoly-sis in healthy humans. Diabetes 2006; 55: 1807-1812
14. Van den Berghe G, Schoonheydt K, Becx P, et al: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353
15. Weekers F, Giulietti AP, Michalaki M, et al: Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003; 144:5329-5338
16. Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008-3013
17. Kovatchev BP, Cox DJ, Gonder-Frederick LA, et al: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care 1997; 20:1655-1658
18. Rood E, Bosman RJ, van der Spoel JI, et al: Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc 2005; 12:172-180
19. Waeschle RM, Moerer O, Hilgers R, et al: The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit Care 2008; 12:R129
20. Ferreira FL, Bota DP, Bross A, et al: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-1758
21. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
22. Kramer AA, Zimmerman JE: Predicting outcomes for cardiac surgery patients after intensive care unit admission. Semin Cardio-thorac Vasc Anesth 2008; 12:175-183
23. Mizock BA: Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15:533-551
24. Quagliaro L, Piconi L, Assaloni R, et al: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52:2795-2804
25. Suh SW, Gum ET, Hamby AM, et al: Hypo-glycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007; 117: 910-918
26. Ceriello A, Esposito K, Piconi L, et al: Oscillating glucose is more deleterious to endo-thelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57:1349-1354
27. Jones SC, Saunders HJ, Qi W, et al: Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubu-lointerstitial cells. Diabetologia 1999; 42: 1113-1119
28. Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005; 19:178-181
29. Dossett LA, Cao H, Mowery NT, et al: Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008; 74:679-685
30. Vanhorebeek IP, Langouche LP, Van den Berghe G: Tight blood glucose control: What is the evidence? Crit Care Med 2007; 35: S496-S502 (Pubitemid 47312185)
31. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223
32. Pinto DS, Skolnick AH, Kirtane AJ, et al: U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 46:178-180
33. Pinto DS, Kirtane AJ, Pride YB, et al: Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 2008; 101:303-307
34. Kosiborod M, Inzucchi SE, Krumholz HM, et al: Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008; 117:1018-1027
35. Bagshaw SMM, Egi MM, George CM, et al: Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009; 37:463-470
36. Krinsley JS, Grover A: Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35:2262-2267
37. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/ surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-3159
38. Vriesendorp TM, DeVries JH, van SS, et al: Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006; 34:2714-2718